Virginia Biotech Research Park Attracts New and International Companies
Thursday, May 21, 2015
Virginia Biotechnology Research Park is now the home to AmpliPhi BioSciences Corporation’s east coast operations in addition to housing their current research lab. Ampliphi, with research facilities in Sydney, Australia and cGMP manufacturing in Europe, is a global leader in the research and development of bacteriophage-based antibacterial therapies to treat multi-drug resistant bacterial infections. In March, the company successfully completed a $13 million financing to support upcoming human clinical trials targeting multi-drug resistant S. aureus including MRSA, which will be conducted at the Walter Reed Army Institute of Research.
Speaking about the move, Chief Business Officer Baxter Phillips III said, “Since beginning my career here in the biotech park with Insmed Incorporated, a successful graduate of the Park, I have watched the biotech park grow several fold from a regional player into a leading life sciences community with national presence. With the strong support of Gov. McAuliffe’s Virginia Biosciences Initiative, and both Jeff Gallagher and Carrie Roth’s leadership in continuing to grow this innovative community, AmpliPhi is very pleased to move our operations to the Park where we can be an integral part of this growth.”
The Research Park also announced RVA Yeast Labs, a leading yeast and bacteria supplier for both professional brewers and home brewers, has established the company’s laboratories in the Park. Malachy McKenna, co-founder of RVA Yeast Labs said, “We are happy to have our lab in the Biotech Center and be a part of the Research Park. The support services and multiple shared resources available to us coupled with the engagement in this innovative community will allow our company to continue to grow, helping to further establish Richmond as a premier community for local craft beer.”
“We are excited these businesses have chosen to be a part of our knowledge-based innovation district. This is a great opportunity for them to become engaged in the innovation ecosystem we are growing in the Richmond region and we are looking forward to having them as residents of our thriving innovative and entrepreneurial community,” stated Carrie Roth, President and CEO of the Research Park.
Four other companies have opened offices or labs in the Biotech Center at the Research Park, including: DNARx and ScienGenix Laboratory, and Lonsa Science and Affinity Molecules are residents in the Shared Lab. Nutriati, a food product startup, has expanded their presence in the Biotech Center. Five other companies have joined as virtual residents of the Virginia Biotechnology Research Park.